Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FANALE, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.326
EU - Europa 2.850
AS - Asia 1.055
SA - Sud America 23
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 11.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.314
IT - Italia 832
FI - Finlandia 651
CN - Cina 513
DE - Germania 451
SG - Singapore 383
UA - Ucraina 213
GB - Regno Unito 161
IE - Irlanda 141
SE - Svezia 108
RU - Federazione Russa 92
RO - Romania 56
BE - Belgio 53
IN - India 49
FR - Francia 34
TR - Turchia 20
CI - Costa d'Avorio 19
IR - Iran 18
KR - Corea 17
HK - Hong Kong 16
BR - Brasile 11
AT - Austria 10
NL - Olanda 10
ES - Italia 9
CA - Canada 8
EU - Europa 8
CH - Svizzera 6
JP - Giappone 6
CZ - Repubblica Ceca 5
KZ - Kazakistan 5
AU - Australia 4
IL - Israele 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BG - Bulgaria 3
CO - Colombia 3
CY - Cipro 3
GR - Grecia 3
PE - Perù 3
TH - Thailandia 3
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
IQ - Iraq 2
LB - Libano 2
PK - Pakistan 2
PL - Polonia 2
VN - Vietnam 2
AL - Albania 1
BH - Bahrain 1
EC - Ecuador 1
EE - Estonia 1
ID - Indonesia 1
LT - Lituania 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11.288
Salva come PNG Salva come JPEG
Città #
Fairfield 1.133
Ashburn 757
Chandler 629
Woodbridge 607
Ann Arbor 480
Wilmington 471
Houston 461
Seattle 429
Cambridge 369
Singapore 317
Palermo 259
Medford 145
Dublin 140
Nanjing 119
Jacksonville 107
New York 103
Des Moines 98
Altamura 96
Princeton 94
Santa Clara 87
Lawrence 78
Dearborn 70
San Diego 66
Boardman 57
Brussels 52
Rome 51
Ludwigshafen am Rhein 50
Beijing 41
Jinan 41
Tulsa 39
Shenyang 35
Hebei 34
Helsinki 32
Bremen 31
Kumar 30
Nanchang 28
Milan 27
Kitzingen 26
London 25
Tianjin 25
Phoenix 23
Venice 22
Changsha 21
Abidjan 19
Los Angeles 18
Munich 18
Ningbo 18
Falls Church 17
Izmir 17
Jiaxing 17
San Paolo di Civitate 16
Saint Petersburg 15
Seongnam 15
Guangzhou 14
Verona 14
Pune 13
San Mateo 12
Tehran 12
Hangzhou 11
Kilburn 11
Redwood City 11
Taiyuan 11
Taizhou 11
Auburn Hills 10
Hanover 10
Norwalk 10
Zhengzhou 10
Dallas 9
Tappahannock 9
Haikou 8
Central 7
Fuzhou 7
Melfi 7
Hounslow 6
Kunming 6
Moscow 6
Orange 6
Tokyo 6
Washington 6
Berlin 5
Chicago 5
Columbus 5
Edinburgh 5
Frankfurt am Main 5
Hong Kong 5
Lanzhou 5
Groningen 4
Hefei 4
Madrid 4
Padova 4
Santa Catarina 4
Yangzhou 4
Central District 3
Chiswick 3
Islington 3
Lima 3
Limassol 3
Mumbai 3
Napoli 3
New Bedfont 3
Totale 8.301
Salva come PNG Salva come JPEG
Nome #
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 216
Dietary restriction: could it be considered as speed bump on tumor progression road? 212
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 202
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 200
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 199
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 193
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 191
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 181
Anti-endothelin drugs in solid tumors 180
A headlight on liquid biopsies: a challenging tool for breast cancer management 179
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 178
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 173
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 170
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 168
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 168
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 165
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 165
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 165
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 164
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 164
The role of Aurora-A inhibitors in cancer therapy. 163
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 163
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 162
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 160
Breast cancer genome-wide association studies: there is strength in numbers 158
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 156
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 155
Gene signatures in CRC and liver metastasis 151
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 151
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 149
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 149
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 149
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 145
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 145
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 143
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 142
VUS variants in BRCA genes of hereditary breast/ovarian cancer 141
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS 139
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 137
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 137
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 137
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 136
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 132
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 131
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 130
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 130
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway 129
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 127
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 127
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 126
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 125
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 125
Non-coding RNAs functioning in colorectal cancer stem cells 123
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies 123
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 118
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 117
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 117
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 116
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 114
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 114
Effects of Dietary Restriction on Cancer Development and Progression 112
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 112
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 104
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 104
Liquid Biopsy in Gastrointestinal Stromal Tumor 100
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 91
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 90
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 89
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 89
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 88
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 86
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 85
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 84
MUTYH-associated tumor syndrome: The other face of MAP 78
Circular RNA in Exosomes 75
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 73
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 73
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 67
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 66
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 64
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 62
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 61
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells 56
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review 54
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 54
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon 53
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 52
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 49
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 48
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 47
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 46
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 44
Gene expression profiling of cumulus oophorus cells reveals altered pathways in patients with endometriosis 43
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 40
Role of CML exosomes in the crosstalk between chronic myelogenous leukemia and bone-marrow derived exosomes 39
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 38
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 30
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology 29
null 25
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 22
Totale 11.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.529 0 0 0 0 0 306 251 198 223 200 275 76
2020/20211.474 86 78 72 98 126 83 98 110 209 209 169 136
2021/20221.348 69 290 49 58 75 61 67 69 128 147 130 205
2022/20231.751 199 344 38 233 194 244 84 128 185 11 59 32
2023/2024977 42 101 54 61 58 214 104 135 6 46 11 145
2024/2025801 23 225 216 171 141 25 0 0 0 0 0 0
Totale 11.805